|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Cerevel Therapeutics Hldg (NASDAQ: CERE) through any online brokerage.
The latest price target for Cerevel Therapeutics Hldg (NASDAQ: CERE) was reported by Morgan Stanley on September 7, 2021. The analyst firm set a price target for 39.00 expecting CERE to fall to within 12 months (a possible -2.72% downside). 5 analyst firms have reported ratings in the last year.
The stock price for Cerevel Therapeutics Hldg (NASDAQ: CERE) is $40.09 last updated Mon Oct 25 2021 20:00:01 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Cerevel Therapeutics Hldg.
Cerevel Therapeutics Hldg’s $Q3 earnings are confirmed for after-market on $November 10, 2021.
There is no upcoming split for Cerevel Therapeutics Hldg.
Cerevel Therapeutics Hldg is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.